These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2940961)

  • 21. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 22. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
    Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
    C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of serotonin antagonists in a behavioral despair procedure in mice.
    Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
    Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors.
    Kawai N; Yamamoto T; Baba A; Yamamoto H; Moroji T
    Arzneimittelforschung; 1994 Jan; 44(1):1-3. PubMed ID: 7907870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP; Jackson DM; Wallsten C; Waszczak BL
    J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin receptors in the brain.
    Haigler HJ; Aghajanian GK
    Fed Proc; 1977 Jul; 36(8):2159-64. PubMed ID: 326580
    [No Abstract]   [Full Text] [Related]  

  • 29. Repeated peripheral administration of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin alters the binding activities of 5-HT1A and 5-HT2 receptors in rat brain.
    Muguruma K; Imamura K; Watanabe Y
    Biochem Biophys Res Commun; 1996 Oct; 227(3):794-9. PubMed ID: 8886012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of serotonergic and adrenergic receptor antagonist on prolactin release in the monkey.
    Gala RR; Subramanian MG; Peters JA; Pieper DR
    Life Sci; 1977 Feb; 20(4):631-7. PubMed ID: 14291
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of cyproheptadine, methysergide, BC 105 and reserpine on brain 5-hydroxytryptamine and brain growth.
    Hole K
    Eur J Pharmacol; 1972 Aug; 19(2):156-9. PubMed ID: 5071787
    [No Abstract]   [Full Text] [Related]  

  • 32. Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist.
    Minnema DJ; Hendry JS; Rosecrans JA
    Psychopharmacology (Berl); 1984; 83(2):200-4. PubMed ID: 6431474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cyproheptadine and pizotifen on central muscarinic receptors.
    Richards MH
    Eur J Pharmacol; 1991 Apr; 195(3):403-5. PubMed ID: 1868883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies of a new anti-migraine drugs. II. To the mode of their central action.
    Metys J; Metysová J; Valchár M; Dlabac A
    Act Nerv Super (Praha); 1979 Oct; 21(3):175-6. PubMed ID: 316258
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of insulin secretion from the perfused pancreas of the rat by pizotifen.
    Joost HG
    Br J Pharmacol; 1979 Oct; 67(2):265-7. PubMed ID: 387147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
    Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
    Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic and serotonergic regulation of skeletal muscle metabolism in the rat: specificity of the serotonin- and isoproterenol-stimulable adenylyl cyclase in sarcolemma.
    Maillet CM; Garber AJ
    Mol Cell Endocrinol; 1986 Dec; 48(2-3):179-90. PubMed ID: 3803707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serotonin and antiserotonergic agents].
    Bourin M
    Rev Prat; 1990 Jun; 40(18):1711-3. PubMed ID: 2371526
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.
    Spira PJ; Mylecharane EJ; Lance JW
    Res Clin Stud Headache; 1976; 4():37-75. PubMed ID: 818690
    [No Abstract]   [Full Text] [Related]  

  • 40. Narcotic cue and narcotic state: differential involvement of brain 5-hydroxytryptamine.
    Colpaert FC; Niemegeers CJ; Kuyps JJ; Janssen PA
    Neuropharmacology; 1977 Jan; 16(1):65-70. PubMed ID: 189248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.